• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 的 ORF6、ORF8 和核衣壳蛋白抑制 I 型干扰素信号通路。

The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway.

机构信息

Institute of Pathogen Biology and Immunology, College of Biology, Hunan Provincial Key Laboratory of Medical Virology, Hunan University, Changsha 410082, Hunan, China.

State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, Hubei, China.

出版信息

Virus Res. 2020 Sep;286:198074. doi: 10.1016/j.virusres.2020.198074. Epub 2020 Jun 23.

DOI:10.1016/j.virusres.2020.198074
PMID:32589897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7309931/
Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel human coronavirus causing the pandemic of severe pneumonia (Coronavirus Disease 2019, COVID-19). SARS-CoV-2 is highly pathogenic in human, having posed immeasurable public health challenges to the world. Innate immune response is critical for the host defense against viral infection and the dysregulation of the host innate immune responses probably aggravates SARS-CoV-2 infection, contributing to the high morbidity and lethality of COVID-19. It has been reported that some coronavirus proteins play an important role in modulating innate immunity of the host, but few studies have been conducted on SARS-CoV-2. In this study, we screened the viral proteins of SARS-CoV-2 and found that the viral ORF6, ORF8 and nucleocapsid proteins were potential inhibitors of type I interferon signaling pathway, a key component for antiviral response of host innate immune. All the three proteins showed strong inhibition on type I interferon (IFN-β) and NF-κB-responsive promoter, further examination revealed that these proteins were able to inhibit the interferon-stimulated response element (ISRE) after infection with Sendai virus, while only ORF6 and ORF8 proteins were able to inhibit the ISRE after treatment with interferon beta. These findings would be helpful for the further study of the detailed signaling pathway and unveil the key molecular player that may be targeted.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)是一种新型人类冠状病毒,可引发严重肺炎大流行(2019 年冠状病毒病,COVID-19)。SARS-CoV-2 在人类中具有高度致病性,对世界造成了不可估量的公共卫生挑战。先天免疫反应对于宿主抵抗病毒感染至关重要,而宿主先天免疫反应的失调可能会加重 SARS-CoV-2 感染,导致 COVID-19 的高发病率和死亡率。据报道,一些冠状病毒蛋白在调节宿主先天免疫方面发挥着重要作用,但针对 SARS-CoV-2 的研究较少。在这项研究中,我们筛选了 SARS-CoV-2 的病毒蛋白,发现病毒 ORF6、ORF8 和核衣壳蛋白可能是宿主先天免疫抗病毒反应的关键组成部分之一——I 型干扰素信号通路的抑制剂。这三种蛋白均对 I 型干扰素(IFN-β)和 NF-κB 反应启动子表现出强烈的抑制作用,进一步的研究表明,这些蛋白在感染仙台病毒后能够抑制干扰素刺激反应元件(ISRE),而只有 ORF6 和 ORF8 蛋白在使用干扰素β处理后能够抑制 ISRE。这些发现有助于进一步研究详细的信号通路,并揭示可能成为靶向目标的关键分子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe5/7309931/9d782311b1b4/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe5/7309931/7a888f2280da/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe5/7309931/9d782311b1b4/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe5/7309931/7a888f2280da/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe5/7309931/9d782311b1b4/gr2_lrg.jpg

相似文献

1
The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway.SARS-CoV-2 的 ORF6、ORF8 和核衣壳蛋白抑制 I 型干扰素信号通路。
Virus Res. 2020 Sep;286:198074. doi: 10.1016/j.virusres.2020.198074. Epub 2020 Jun 23.
2
Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists.严重急性呼吸综合征冠状病毒开放阅读框(ORF)3b、ORF 6和核衣壳蛋白作为干扰素拮抗剂发挥作用。
J Virol. 2007 Jan;81(2):548-57. doi: 10.1128/JVI.01782-06. Epub 2006 Nov 15.
3
Activation and evasion of type I interferon responses by SARS-CoV-2.SARS-CoV-2 激活和逃避 I 型干扰素应答。
Nat Commun. 2020 Jul 30;11(1):3810. doi: 10.1038/s41467-020-17665-9.
4
SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection.SARS-CoV-2 ORF6 蛋白在感染呼吸道上皮细胞 Calu-3 时不会拮抗干扰素信号。
mBio. 2023 Aug 31;14(4):e0119423. doi: 10.1128/mbio.01194-23. Epub 2023 Jun 28.
5
Manipulation of innate immune signaling pathways by SARS-CoV-2 non-structural proteins.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)非结构蛋白对固有免疫信号通路的调控
Front Microbiol. 2022 Nov 21;13:1027015. doi: 10.3389/fmicb.2022.1027015. eCollection 2022.
6
Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.中东呼吸综合征冠状病毒核衣壳蛋白通过靶向 RIG-I 信号抑制 I 型和 III 型干扰素的诱导。
J Virol. 2020 Jun 16;94(13). doi: 10.1128/JVI.00099-20.
7
SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)的Orf9b蛋白通过靶向TOM70抑制I型干扰素反应。
Cell Mol Immunol. 2020 Sep;17(9):998-1000. doi: 10.1038/s41423-020-0514-8. Epub 2020 Jul 29.
8
SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.SARS-CoV-2 非结构蛋白 1 通过导致关键宿主信号因子耗竭来抑制干扰素反应。
J Virol. 2021 Jun 10;95(13):e0026621. doi: 10.1128/JVI.00266-21.
9
Phosphatase Cdc25A Negatively Regulates the Antiviral Immune Response by Inhibiting TBK1 Activity.磷酸酶 Cdc25A 通过抑制 TBK1 活性负调控抗病毒免疫反应。
J Virol. 2018 Sep 12;92(19). doi: 10.1128/JVI.01118-18. Print 2018 Oct 1.
10
SARS-CoV-2 NSP12 Protein Is Not an Interferon-β Antagonist.SARS-CoV-2 NSP12 蛋白不是干扰素-β 拮抗剂。
J Virol. 2021 Aug 10;95(17):e0074721. doi: 10.1128/JVI.00747-21.

引用本文的文献

1
SARS-CoV-2 infection induces pro-fibrotic and pro-thrombotic foam cell formation.新型冠状病毒2型感染会诱导促纤维化和促血栓形成的泡沫细胞形成。
Nat Microbiol. 2025 Aug 22. doi: 10.1038/s41564-025-02090-9.
2
The P132H mutation of SARS-CoV-2 NSP5 relieves its inhibition on interferon-β activation via blocking MAVS degradation.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)非结构蛋白5(NSP5)的P132H突变通过阻断线粒体抗病毒信号蛋白(MAVS)降解来解除其对干扰素-β激活的抑制作用。
Cell Mol Life Sci. 2025 Jul 30;82(1):293. doi: 10.1007/s00018-025-05822-6.
3
Association between Guillain-Barré syndrome and SARS-CoV-2 virus infection, including the impact of COVID-19 vaccination in the context of the development and general clinical characteristics of the disease.

本文引用的文献

1
SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant.SARS-CoV-2 ORF3b 是一种有效的干扰素拮抗剂,其活性可被一种自然发生的延长变异体增强。
Cell Rep. 2020 Sep 22;32(12):108185. doi: 10.1016/j.celrep.2020.108185. Epub 2020 Sep 4.
2
SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East.台湾地区的 SARS-CoV-2 基因组监测揭示了新型 ORF8 缺失突变株和可能与中东感染相关的分支。
Emerg Microbes Infect. 2020 Dec;9(1):1457-1466. doi: 10.1080/22221751.2020.1782271.
3
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.
吉兰-巴雷综合征与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染之间的关联,包括在该疾病的发展和一般临床特征背景下2019冠状病毒病(COVID-19)疫苗接种的影响。
J Neurovirol. 2025 Jul 7. doi: 10.1007/s13365-025-01267-6.
4
SARS-CoV-2 ORF7a Protein Impedes Type I Interferon-Activated JAK/STAT Signaling by Interacting with HNRNPA2B1.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的ORF7a蛋白通过与异质性核糖核蛋白A2B1(HNRNPA2B1)相互作用来阻碍I型干扰素激活的JAK/STAT信号传导。
Int J Mol Sci. 2025 Jun 10;26(12):5536. doi: 10.3390/ijms26125536.
5
Innate immunity, therapeutic targets and monoclonal antibodies in SARS-CoV-2 infection.新型冠状病毒感染中的固有免疫、治疗靶点及单克隆抗体
PeerJ. 2025 Jun 20;13:e19462. doi: 10.7717/peerj.19462. eCollection 2025.
6
SARS-CoV-2 nucleocapsid protein directly prevents cGAS-DNA recognition through competitive binding.严重急性呼吸综合征冠状病毒2核衣壳蛋白通过竞争性结合直接阻止环鸟苷酸-腺苷酸合成酶与DNA的识别。
Proc Natl Acad Sci U S A. 2025 Jul;122(26):e2426204122. doi: 10.1073/pnas.2426204122. Epub 2025 Jun 23.
7
Intrinsic factors behind long COVID: exploring the role of nucleocapsid protein in thrombosis.长期新冠背后的内在因素:探索核衣壳蛋白在血栓形成中的作用
PeerJ. 2025 May 20;13:e19429. doi: 10.7717/peerj.19429. eCollection 2025.
8
The whole genome analysis of the wild-type and attenuated orf virus reveals that ORF022 facilitates viral replication.野生型和减毒orf病毒的全基因组分析表明,ORF022促进病毒复制。
BMC Genomics. 2025 May 15;26(1):488. doi: 10.1186/s12864-025-11663-1.
9
Beyond Infection: The Role of Secreted Viral Proteins in Pathogenesis, Disease Severity and Diagnostic Applications.超越感染:分泌型病毒蛋白在发病机制、疾病严重程度及诊断应用中的作用
Cells. 2025 Apr 22;14(9):624. doi: 10.3390/cells14090624.
10
Biological Significance and Therapeutic Promise of Programmed Ribosomal Frameshifting.程序性核糖体移码的生物学意义与治疗前景
Int J Mol Sci. 2025 Feb 3;26(3):1294. doi: 10.3390/ijms26031294.
COVID-19 中的免疫反应:通过靶向 SARS-CoV-2 触发的途径来应对药理学挑战。
Signal Transduct Target Ther. 2020 May 29;5(1):84. doi: 10.1038/s41392-020-0191-1.
4
Coronavirus Endoribonuclease and Deubiquitinating Interferon Antagonists Differentially Modulate the Host Response during Replication in Macrophages.冠状病毒内切核糖核酸酶和去泛素化干扰素拮抗剂在巨噬细胞复制过程中对宿主反应的调节作用不同。
J Virol. 2020 May 18;94(11). doi: 10.1128/JVI.00178-20.
5
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
6
Coronavirus Endoribonuclease Activity in Porcine Epidemic Diarrhea Virus Suppresses Type I and Type III Interferon Responses.冠状病毒内切核酸酶活性在猪流行性腹泻病毒中抑制 I 型和 III 型干扰素反应。
J Virol. 2019 Apr 3;93(8). doi: 10.1128/JVI.02000-18. Print 2019 Apr 15.
7
Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission.在人际传播早期获得的 SARS-CoV 29 个核苷酸缺失可减弱复制。
Sci Rep. 2018 Oct 11;8(1):15177. doi: 10.1038/s41598-018-33487-8.
8
Combination Attenuation Offers Strategy for Live Attenuated Coronavirus Vaccines.联合衰减为活减冠状病毒疫苗提供策略。
J Virol. 2018 Aug 16;92(17). doi: 10.1128/JVI.00710-18. Print 2018 Sep 1.
9
Genome-wide identification of interferon-sensitive mutations enables influenza vaccine design.全基因组鉴定干扰素敏感性突变可用于流感疫苗设计。
Science. 2018 Jan 19;359(6373):290-296. doi: 10.1126/science.aan8806.
10
MERS-CoV Accessory ORFs Play Key Role for Infection and Pathogenesis.MERS-CoV 辅助 ORFs 对感染和发病机制起着关键作用。
mBio. 2017 Aug 22;8(4):e00665-17. doi: 10.1128/mBio.00665-17.